Cargando…
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
Androgen receptor (AR) is expressed in 80% to 90% of estrogen receptor α–positive (ER(+)) breast cancers. Accumulated evidence has shown that AR is a tumor suppressor and that its expression is associated with improved prognosis in ER(+) breast cancer. However, both a selective AR agonist (RAD140) a...
Autores principales: | Wei, Lixuan, Gao, Huanyao, Yu, Jia, Zhang, Huan, Nguyen, Thanh Thanh L., Gu, Yayun, Passow, Marie R., Carter, Jodi M., Qin, Bo, Boughey, Judy C., Goetz, Matthew P., Weinshilboum, Richard M., Ingle, James N., Wang, Liewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896025/ https://www.ncbi.nlm.nih.gov/pubmed/36469363 http://dx.doi.org/10.1158/0008-5472.CAN-22-1016 |
Ejemplares similares
-
ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion
por: Qin, Sisi, et al.
Publicado: (2021) -
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022) -
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion
por: Qin, Sisi, et al.
Publicado: (2017) -
Glucocorticoids mediate transcriptome‐wide alternative polyadenylation: Potential mechanistic and clinical implications
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2022) -
3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction
por: Zhang, Huan, et al.
Publicado: (2022)